NCT02905812

Brief Summary

Methodology: Pilot randomized controlled trial with 1 intervention and 1 parallel standard care group to assess the feasibility and treatment effect of a multimodal integrative intervention for delirium prevention and associated detrimental effects. Duration: 2 years, two months. Study Center(s): Multi-center (2 sites) Aim: To assess feasibility and measures of effect of a multimodal intervention consisting of relaxation with guided imagery (RGI), and moderate pressure massage on physiological and psychological outcomes of critically ill patients. Objectives: a) assess clinical trial feasibility with pre-defined goals (enrollment, randomization, adherence, timing of intervention, workload), b) calculate estimates and variance of treatment effect across outcome measures, c) calculate confidence intervals (CI) of incidence proportions, means and standard deviation (SD) of outcome measures in study groups., d) explore underlying physiological mechanisms of efficacy Number of Subjects: 60 participants per arm. Total: 120 participants Diagnosis and Main Inclusion Criteria: Critical illness Inclusion criteria: a) Age over 18 years, b) ICDSC:0-3. Exclusion Criteria: Patients: a) with expected ICU LOS\< 72 hours, b) with acute neurological illness/ trauma, persistent sedation or coma, c) with current history of severe mental health problems and dementia, as per history and psychiatrist assessment, c) with hearing impairment or conditions not permitting use of headphones, e) on neuro-muscular blockers, f) with substance/ alcohol withdrawal, g) enrolled in trials of sedatives, antipsychotics. Intervention: REPOSE intervention (a multimodal relaxation intervention) It includes: a) relaxation and guided imagery (RGI) (40 min, headphones), b) a brief moderate pressure massage session (massage: 15 min). RGI involves: a) guided relaxation, b) a structured guided imagery script and c) music for 15 min (Mozart piano sonata KV283, G major (2 3) II Andante). Duration of administration: Up to 5 days while participants still in the ICU. Reference therapy: Standard care plus placebo to maintain blinding. Statistical Methodology: Outcomes will be analyzed longitudinally over 5 days by logistic regression model based on generalized estimating equations (GEE) with AR(1) correlation structure. Confidence intervals will be presented with estimated effects. Primary analysis will be based on all available data utilizing data from all assessments.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27

participants targeted

Target at below P25 for not_applicable

Timeline
12mo left

Started Mar 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress88%
Mar 2019May 2027

First Submitted

Initial submission to the registry

August 22, 2016

Completed
28 days until next milestone

First Posted

Study publicly available on registry

September 19, 2016

Completed
2.4 years until next milestone

Study Start

First participant enrolled

March 1, 2019

Completed
8.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2027

Last Updated

May 11, 2026

Status Verified

May 1, 2026

Enrollment Period

8.3 years

First QC Date

August 22, 2016

Last Update Submit

May 5, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Feasibility 1: Recruitment rate (percentage of patients recruited among eligible patients)

    recruitment rate (percentage of patients recruited among eligible patients)

    up to 2 years

Secondary Outcomes (20)

  • Eligibility (percentage (%) of eligible patients among patients screened)

    up to 2 years

  • Enrollment [Time (min) from admission to enrollment]

    up to 2 years

  • Reasons for delayed enrollment (content analysis categories & descriptive statistics of free-text entries describing reasons for delay)

    up to 2 years

  • Non-Consent (Percentage of eligible patients declining consent)

    up to 2 years

  • Protocol completion (Percentage of participants completing the entire study protocol)

    Up to 25 months

  • +15 more secondary outcomes

Other Outcomes (23)

  • NRS Pain intensity [self-reported (S-R) Numeric Rating Scale (NRS)]

    Up to 30 days (Pre- & post- intervention during first 5 days)

  • Pain ratings [Critical Care Pain Observation Tool (CPOT)]

    Up to 30 days (Pre- & post- intervention during first 5 days)

  • Pain distress (self-reported (S-R) numeric rating scale (NRS)

    Up to 30 days (Pre- & post- intervention during first 5 days)

  • +20 more other outcomes

Study Arms (2)

RGI & Massage

ACTIVE COMPARATOR

1. relaxation and guided imagery with background music (RGI) (40 min, headphones) 2. a brief moderate pressure massage session (massage: 15 min)

Other: RGI & Massage

Control

NO INTERVENTION

Sham intervention: Silent headphones to mask the audio component, and presence of an intervention nurse at the bedside with drawn curtains.

Interventions

A trained intervention nurse will administer a 15 min moderate pressure massage as well as guided imagery with music once daily for up to five consecutive days.

RGI & Massage

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients hospitalized in one of the study Intensive Care Units (ICUs)
  • Age over 18 years
  • Intensive Care Delirium Screening Checklist (ICDSC):0-3
  • patients enrolled in other investigative trials not involving sedative, psychoactive medications

You may not qualify if:

  • patients with expected Intensive Care Unit length of stay \< 72 hours
  • patients with acute neurological illness/ trauma, persistent sedation or coma
  • patients with current history of severe mental health problems and dementia, as per history and psychiatrist assessment
  • patients with hearing impairment or conditions not permitting use of headphones
  • patients on neuro-muscular blocker medications
  • patients with substance/ alcohol withdrawal
  • patients enrolled in trials of sedatives, antipsychotics

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Misreicordia Hospital

Edmonton, Alberta, T5R 4H5, Canada

Location

Related Publications (1)

  • Papathanassoglou EDE, Skrobik Y, Hegadoren K, Thompson P, Stelfox HT, Norris C, Rose L, Bagshaw SM, Meier M, LoCicero C, Ashmore R, Sparrow Brulotte T, Hassan I, Park T, Kutsogiannis DJ. Relaxation for Critically ill Patient Outcomes and Stress-coping Enhancement (REPOSE): a protocol for a pilot randomised trial of an integrative intervention to improve critically ill patients' delirium and related outcomes. BMJ Open. 2019 Jan 15;9(1):e023961. doi: 10.1136/bmjopen-2018-023961.

MeSH Terms

Conditions

Delirium

Interventions

Massage

Condition Hierarchy (Ancestors)

ConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Therapy, Soft TissueMusculoskeletal ManipulationsComplementary TherapiesTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Officials

  • Elisavet Papathanasoglou, PhD

    University of Alberta

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 22, 2016

First Posted

September 19, 2016

Study Start

March 1, 2019

Primary Completion (Estimated)

May 31, 2027

Study Completion (Estimated)

May 31, 2027

Last Updated

May 11, 2026

Record last verified: 2026-05

Locations